(NASDAQ: PRCT) Procept Biorobotics's forecast annual revenue growth rate of 28.51% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.27%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.4%.
Procept Biorobotics's revenue in 2025 is $249,121,000.On average, 7 Wall Street analysts forecast PRCT's revenue for 2025 to be $17,986,962,666, with the lowest PRCT revenue forecast at $17,850,134,870, and the highest PRCT revenue forecast at $18,519,279,781. On average, 7 Wall Street analysts forecast PRCT's revenue for 2026 to be $23,603,431,083, with the lowest PRCT revenue forecast at $22,955,864,353, and the highest PRCT revenue forecast at $24,844,895,736.
In 2027, PRCT is forecast to generate $29,259,072,198 in revenue, with the lowest revenue forecast at $27,503,880,863 and the highest revenue forecast at $32,165,819,100.